The Genio system is a battery-free, leadless, MRI-compatible neurostimulator for moderate to severe Obstructive Sleep Apnea (OSA), using bilateral nerve stimulation.
Obstructive Sleep Apnea (OSA) affects nearly 936 million people aged 30–69 globally, with 425 million experiencing moderate to severe cases requiring treatment.
Robert Taub is a serial entrepreneur and investor in several pharmaceutical and medical device companies. He gained an MBA at INSEAD and held various general management and sales and marketing positions with Monsanto, Baxter Travenol Laboratories and the Revlon Health Care Group.
Liam Kelly joined Nyxoah as Chief Executive Officer in October 2026, bringing over 25 years of leadership experience, including roles at Teleflex Incorporated (NYSE: TFX).
Make Sleep Simple Mission Become a world leading company by offering unique patient-centric neuromodulation solutions, developed by passionate and exceptionally driven people
